Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sacral Neuromodulation for Patients With Multiple Sclerosis With Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction. A Multicenter Double-blind, Placebo-controlled Randomized Clinical Trial.

NCT05380856 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT05380856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05380856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sacral Neuromodulation for Patients With Multiple Sclerosis With Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction. A Multicenter Double-blind, Placebo-controlled Randomized Clinical Trial.
Lead sponsor
Odense University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 26, 2023
Completion date
March 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bowel dysfunction, multiple sclerosis, neurogenic dysfunction of the urinary bladder, quality of life, sacral neuromodulation, sexual dysfunction